| Patents for C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576) |
|---|
| 06/13/2002 | US20020072624 As antiestrogenic and anti-proliferative agent |
| 05/30/2002 | US20020065257 17beta-amino and hydroxylamino-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/23/2002 | WO2001087284A3 Aldosterone antagonist composition for release during aldosterone acrophase |
| 05/16/2002 | WO2002038582A2 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 05/16/2002 | WO2002038581A2 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 05/16/2002 | DE10056676A1 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from epoxy-estrenone by multi-stage process including selective Grignard reaction |
| 05/16/2002 | DE10056675A1 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from estradienone by multi-stage process including selective Grignard reaction |
| 05/10/2002 | WO2002036606A1 Selective glucocorticoid receptor agonists |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 04/18/2002 | US20020045746 Form L crystalline eplerenone having a monoclinic crystal system and an X-ray powder diffraction pattern with a peak at 8. 0+-0.2 degrees 2 theta . |
| 04/11/2002 | US20020042507 Process for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 03/28/2002 | WO2002024715A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 03/28/2002 | US20020038021 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 03/20/2002 | EP0730458B1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 03/07/2002 | WO2002017895A2 Use of an aldosterone receptor antagonist to improve cognitive function |
| 03/07/2002 | CA2419256A1 Use of an aldosterone receptor antagonist to improve cognitive function |
| 03/06/2002 | CN1080267C Preparation of intermediat of 19, 11 beta-bridge steroid |
| 03/05/2002 | US6352697 Immunostimulating complex matrices; quil a fractions |
| 02/28/2002 | US20020025951 Urogenital disorders |
| 02/14/2002 | US20020019522 Steroids |
| 02/07/2002 | WO2002009760A2 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/07/2002 | WO2002009759A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/07/2002 | WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | US20020016455 Epoxidation of cyclopenta(a)phenanthrene derivatives |
| 02/07/2002 | CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | CA2415789A1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/07/2002 | CA2415078A1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 01/09/2002 | EP1170299A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 01/02/2002 | EP1167381A2 Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein |
| 01/02/2002 | EP1167380A2 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/01/2002 | US6335441 5β-cyano-substituted steroid compounds |
| 12/18/2001 | US6331622 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 12/18/2001 | US6331534 Steroids as neurochemical stimulators of the VNO to alleviate pain |
| 12/12/2001 | EP0785802B1 Saponin preparations and use thereof in iscoms |
| 12/12/2001 | CN1326461A Meiosis regulating compounds |
| 11/22/2001 | WO2001087284A2 Aldosterone antagonist composition for release during aldosterone acrophase |
| 11/22/2001 | CA2409437A1 Aldosterone antagonist composition for release during aldosterone acrophase |
| 11/14/2001 | CN1322130A Inhibitors of type 3 3a -hydrosteroid dehydrogenase |
| 10/25/2001 | WO2001079255A1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
| 10/24/2001 | EP1148061A2 Process for preparation of 9, 11- epoxy steroids and intermediates useful therein |
| 10/11/2001 | WO2001074839A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 10/04/2001 | WO2001072293A2 Antiprogestins with partial agonist activity |
| 10/04/2001 | CA2404172A1 Antiprogestins with partial agonist activity |
| 09/12/2001 | EP1131336A1 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 08/28/2001 | US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions |
| 07/17/2001 | US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/11/2001 | EP0735819B1 Cryptophycins |
| 07/11/2001 | CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/10/2001 | US6258946 Chemical intermediate for diuretic |
| 07/10/2001 | US6258803 11-ethyl-17-hydroxy-19-norpregn-4-en-20-yn-3-one for menopause treatment |
| 07/05/2001 | WO2001047945A1 Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 06/14/2001 | US20010003782 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells |
| 05/30/2001 | EP1102582A2 Inhibitors of type 3 3alpha-hydroxysteroid dehydrogenase |
| 05/02/2001 | EP1094798A2 INHIBITORS OF TYPE 5 AND TYPE 3 17beta-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 03/21/2001 | EP0738275B9 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 03/14/2001 | EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/07/2001 | CN1286694A Novel 19-norsteroids substd in position 11 'beta', preparation method and intermediates, application as medicines and pharmaceutical compositions contg. them |
| 02/28/2001 | EP1077992A1 Meiosis regulating compounds |
| 02/22/2001 | WO1999046279A3 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 02/14/2001 | CN1061983C 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof |
| 01/30/2001 | US6180803 Steroid drugs |
| 01/30/2001 | US6180780 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 01/23/2001 | US6177418 Epoxidized and/or hydroxylated prostane derivatives derived from a fusidium coccineum fungus metabolite isolated from metabolite mixture of fusidic acid |
| 12/05/2000 | CA2027627C Process for preparing 21-desoxyprednisolone 17-esters |
| 11/21/2000 | US6150336 Steroidal glycosides |
| 11/08/2000 | EP0738275B1 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 11/08/2000 | EP0650495B1 Improved antiandrogens |
| 10/25/2000 | CN1057770C Application of 19,11 beta-bridged sterodal compound in pharmaceutical working |
| 10/11/2000 | CN1057304C 17,20-epoxide derivatives of pregnance, their preparation, their use in preparation of cortisome derivatives and intermediates |
| 10/11/2000 | CN1057303C Preparation process for 16 beta-methyl steroid and new intermediates thereof |
| 09/12/2000 | US6117994 Intermediates for 16β-methyl steroids |
| 09/12/2000 | US6117860 Nasally administering steroid which binds to a specific neuroepithelial receptor for alleviating premenstrual tension and anxiety |
| 09/06/2000 | EP1032584A1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them |
| 08/30/2000 | CN1055930C Steroalkenol polyfluohydrocarbyl sulfonate compound and its deriv., use and preparing process |
| 08/29/2000 | US6110906 Androgen derivatives for use in the inhibition of sex steroid activity |
| 08/22/2000 | US6107036 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 07/11/2000 | CA2016780C Dihydrospirorenone as an antiandrogen |
| 07/05/2000 | EP0900234B1 21-substituted progesterone derivatives as new antiprogestational agents |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 07/05/2000 | CN1259137A Estra-5(10), 7-dienes with estrogenic activity |
| 07/05/2000 | CN1054133C 17-spiromethylene steroids |
| 07/04/2000 | US6083940 Method and composition for effecting contraception in a mammalian male |
| 06/13/2000 | CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates |
| 06/06/2000 | US6072068 Treating glucocorticoid-dependent diseases or symptoms |
| 06/02/2000 | WO2000031112A1 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 05/17/2000 | CN1253564A Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 05/10/2000 | CN1052237C Steroids with 17-spiromethylene lactone or ortho -hydroxyl inner ether base |
| 05/09/2000 | US6060503 Antiestrogenic, anticarcinogenic stereospecific benzopyran derivative; breast cancer |
| 05/02/2000 | US6057439 Epoxysteroids |
| 04/04/2000 | US6046185 6,7-oxygenated steroids and uses related thereto |
| 03/30/2000 | WO2000007576A3 INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE |
| 03/22/2000 | CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 03/14/2000 | US6037339 C-11 substituted steroids for treating menopausal complaints |
| 03/01/2000 | EP0982298A1 Novel functionalized hydrophilic acridinium esters |
| 02/17/2000 | WO2000007576A2 INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE |
| 02/17/2000 | CA2339368A1 Inhibitors of type 3 3.alpha.-hydroxysteroid dehydrogenase |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973791A2 Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds |